Saskia M. Wilting

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Overall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer: A Randomized Clinical Trial.

Overall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer: A Randomized Clinical Trial.

Journal: JAMA oncology

Published: February 19, 2026

Longitudinal genome-wide aneuploidy measurements in circulating cell-free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer.

Longitudinal genome-wide aneuploidy measurements in circulating cell-free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer.

Journal: Molecular oncology

Published: November 10, 2025

Prognostic value of peri-operative circulating tumour DNA levels estimated by cell-free DNA methylation in patients with resectable colorectal liver metastases.

Prognostic value of peri-operative circulating tumour DNA levels estimated by cell-free DNA methylation in patients with resectable colorectal liver metastases.

Journal: EBioMedicine

Published: October 21, 2025

Presurgical levels of circulating tumour DNA in patients with resectable chemotherapy-naïve colorectal liver metastases: association with multiorgan recurrence and survival in the MIRACLE cohort.

Presurgical levels of circulating tumour DNA in patients with resectable chemotherapy-naïve colorectal liver metastases: association with multiorgan recurrence and survival in the MIRACLE cohort.

Journal: The British journal of surgery

Published: September 08, 2025

Improved circulating tumor DNA profiling by simultaneous extraction of DNA methylation and copy number information from methylated DNA sequencing data.

Improved circulating tumor DNA profiling by simultaneous extraction of DNA methylation and copy number information from methylated DNA sequencing data.

Journal: NPJ precision oncology

Published: May 27, 2025

Methylated CfDNA may distinguish between high- and intermediate-risk uveal melanoma: a pilot study.

Methylated CfDNA may distinguish between high- and intermediate-risk uveal melanoma: a pilot study.

Journal: Cancer cell international

Published: April 01, 2025

Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker study.

Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker study.

Journal: EClinicalMedicine

Published: March 26, 2025

Circulating tumour DNA and melanoma: time to take the leap?

Circulating tumour DNA and melanoma: time to take the leap?

Journal: The Lancet. Oncology

Published: March 24, 2025

Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial.

Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial.

Journal: Nature medicine

Published: February 24, 2025

Clinicopathological and molecular characterization of inflammatory breast cancer, the prospective INFLAME registry study.

Clinicopathological and molecular characterization of inflammatory breast cancer, the prospective INFLAME registry study.

Journal: NPJ breast cancer

Published: February 11, 2025

Genome-Wide Methylation Sequencing to Identify DNA Methylation Markers for Early-stage Hepatocellular Carcinoma in Liver and Blood.

Genome-Wide Methylation Sequencing to Identify DNA Methylation Markers for Early-stage Hepatocellular Carcinoma in Liver and Blood.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 24, 2025

The colorectal liver metastasis growth pattern phenotype is not dependent on genotype.

The colorectal liver metastasis growth pattern phenotype is not dependent on genotype.

Journal: British journal of cancer

Published: December 09, 2024

Showing 1-12 of 83

Last Updated: 09/26/2026